Migraine

SEATTLE, June 17, 2026 Vedana Therapeutics has officially emerged from stealth with $46 million in Series A financing to...

BAGSVAERD, Denmark, May 12, 2026 Novo Nordisk announced new clinical findings at the 2026 European Congress on Obesity (ECO...